Vasculitides and the Complement System: a Comprehensive Review

被引:51
作者
Chimenti, Maria Sole [1 ]
Ballanti, Eleonora [1 ]
Triggianese, Paola [1 ]
Perricone, Roberto [1 ]
机构
[1] Univ Roma Tor Vergata, Rheumatol Allergol & Clin Immunol Dept Med Sistem, I-00133 Rome, Italy
关键词
Complement system; Vasculitides; Urticarial vasculitis; ANCA; Cryoglobulinemia; Anti-complement therapy; BASEMENT-MEMBRANE ANTIBODY; HENOCH-SCHONLEIN PURPURA; MANNOSE-BINDING LECTIN; KAWASAKI-DISEASE; INTRAVENOUS IMMUNOGLOBULINS; T-CELLS; ANCA; PATHWAY; ACTIVATION; GRANULOMATOSIS;
D O I
10.1007/s12016-014-8453-8
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Systemic vasculitides are a group of rare diseases characterized by inflammation of the arterial or venous vessel wall, causing stenosis or thrombosis. Clinical symptoms may be limited to skin or to other organs or may include multiple manifestations as systemic conditions. The pathogenesis is related to the presence of leukocytes in the vessels and to the IC deposition, which implies the activation of the complement system (CS) and then the swelling and damage of vessel mural structures. The complement system (CS) is involved in the pathogenesis of several autoimmune diseases, including systemic vasculitides. This enzymatic system is a part of the innate immune system, and its function is linked to the modulation of the adaptive immunity and in bridging innate and adaptive responses. Its activation is also critical for the development of natural antibodies and T cell response and for the regulation of autoreactive B cells. Complement triggering contributes to inflammation-driven tissue injury, which occurs during the ischemia/reperfusion processes, vasculitides, nephritis, arthritis, and many others diseases. In systemic vasculitides, a group of uncommon diseases characterized by blood vessel inflammation, the contribution of CS in the development of inflammatory damage has been demonstrated. Treatment is mainly based on clinical manifestations and severity of organ involvement. Evidences on the efficacy of traditional immunosuppressive therapies have been collected as well as data from clinical trials that involve the modulation of the CS. In particular in small-medium-vessel vasculitides, the CS represents an attractive target. Herein, we reviewed the pathogenetic role of CS in these systemic vasculitides as urticarial vasculitis, ANCA-associated vasculitides, anti-glomerular basement membrane disease, cryoglobulinaemic vasculitides, Henoch-Schonlein purpura/IgA nephropathy, and Kawasaki disease and therefore its potential therapeutic use in this context.
引用
收藏
页码:333 / 346
页数:14
相关论文
共 89 条
[1]   Complement and autoimmunity [J].
Ballanti, Eleonora ;
Perricone, Carlo ;
Greco, Elisabetta ;
Ballanti, Marta ;
Di Muzio, Gioia ;
Chimenti, Maria Sole ;
Perricone, Roberto .
IMMUNOLOGIC RESEARCH, 2013, 56 (2-3) :477-491
[2]  
Ballanti E, 2012, ISR MED ASSOC J, V14, P583
[3]   The IgG molecule as a biological immune response modifier: Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders [J].
Ballow, Mark .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) :315-323
[4]   Infection and vasculitis [J].
Belizna, Cristina C. ;
Hamidou, Mohamed A. ;
Levesque, Herve ;
Guillevin, Loic ;
Shoenfeld, Yehuda .
RHEUMATOLOGY, 2009, 48 (05) :475-482
[5]   Polymorphisms in the mannose-binding lectin gene as determinants of age-defined risk of coronary artery lesions in Kawasaki disease [J].
Biezeveld, MH ;
Geissler, J ;
Weverling, GJ ;
Kuipers, IM ;
Lam, J ;
Ottenkamp, J ;
Kuijpers, TW .
ARTHRITIS AND RHEUMATISM, 2006, 54 (01) :369-376
[6]   What's new in the aetiopathogenesis of vasculitis? [J].
Brogan, Paul A. .
PEDIATRIC NEPHROLOGY, 2007, 22 (08) :1083-1094
[7]  
BROUET JC, 1974, AM J MED, V57, P775, DOI 10.1016/0002-9343(74)90852-3
[8]  
BROUWER E, 1991, CLIN EXP IMMUNOL, V83, P379
[9]   Kawasaki syndrome [J].
Burns, JC ;
Glodé, MP .
LANCET, 2004, 364 (9433) :533-544
[10]   Hepatitis C virus infection induced vasculitis [J].
Cacoub, Patrice ;
Saadoun, David .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2008, 35 (1-2) :30-39